Previous 10 | Next 10 |
2024-02-18 11:27:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Growth Fund (the Fund) gained 7.70% (Institutional Shares) for the quarter and 1...
2024-02-18 07:20:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron WealthBuilder Fund appreciated 11.42% (inst.) in Q4 2023, and for 2023, the Fund...
2024-02-17 10:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Focused Growth Fund increased 9.74% (inst. shares) in Q4 2023 underperforming th...
2024-02-17 05:25:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund was up 12.64% (Institutional Shares) in Q4 2023 and gained 27.19%...
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect Canada NewsWire Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits WESTBROOK, Maine , ...
2024-02-07 07:58:28 ET Summary IDEXX Laboratories reported strong financial performance in 4Q23, with an 8% increase in organic revenues. The company experienced growth in its Companion Animal Group segment, particularly in diagnostic recurring revenue. IDEXX's outlook include...
A look at the top 10 most actives in the United States Phunware Inc. (PHUN) rose 19.9% to $0.41 on volume of 260,182,609 shares Palantir Technologies Inc. Class A (PLTR) fell 1.8% to $16.72 on volume of 167,698,349 shares PROSHARES TRUST (SQQQ) rose 0.5% to $11.78 on volume of 155,646,888...
2024-02-05 12:02:03 ET IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Conference Call February 05, 2024, 8:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conf...
2024-02-05 06:34:13 ET More on IDEXX Laboratories IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified Piper Sandler downgrades Idexx to neutral, cites macro headwinds Seeking Alpha’s Quant Rating on IDEXX Laboratories Historical earnings data...
Achieves fourth quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 11% reported and 10% organic Solid growth supported by continued benefits from IDEXX execution drivers, including 11% year-over-year expansion of IDEXX's global prem...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...